Borosil Renewables Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 17, 2025, 8:27 pm

Competitors of Borosil Renewables Ltd

All Competitor Stocks of Borosil Renewables Ltd

Quarterly Result

Last Updated: May 31, 2025, 9:36 am

Below is a detailed analysis of the quarterly data for Borosil Renewables Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 374.00 Cr.. The value appears strong and on an upward trend. It has increased from 361.00 Cr. (Dec 2024) to 374.00 Cr., marking an increase of 13.00 Cr..
• For Expenses, as of Mar 2025, the value is 358.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 372.00 Cr. (Dec 2024) to 358.00 Cr., marking a decrease of 14.00 Cr..
• For Operating Profit, as of Mar 2025, the value is 15.00 Cr.. The value appears strong and on an upward trend. It has increased from -10.00 Cr. (Dec 2024) to 15.00 Cr., marking an increase of 25.00 Cr..
• For OPM %, as of Mar 2025, the value is 4.00%. The value appears strong and on an upward trend. It has increased from -3.00% (Dec 2024) to 4.00%, marking an increase of 7.00%.
• For Other Income, as of Mar 2025, the value is 12.00 Cr.. The value appears to be declining and may need further review. It has decreased from 15.00 Cr. (Dec 2024) to 12.00 Cr., marking a decrease of 3.00 Cr..
• For Interest, as of Mar 2025, the value is 10.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 5.00 Cr. (Dec 2024) to 10.00 Cr., marking an increase of 5.00 Cr..
• For Depreciation, as of Mar 2025, the value is 36.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 32.00 Cr. (Dec 2024) to 36.00 Cr., marking an increase of 4.00 Cr..
• For Profit before tax, as of Mar 2025, the value is -18.00 Cr.. The value appears strong and on an upward trend. It has increased from -32.00 Cr. (Dec 2024) to -18.00 Cr., marking an increase of 14.00 Cr..
• For Tax %, as of Mar 2025, the value is 60.00%. The value appears to be increasing, which may not be favorable. It has increased from -6.00% (Dec 2024) to 60.00%, marking an increase of 66.00%.
• For Net Profit, as of Mar 2025, the value is -30.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded -30.00 Cr..
• For EPS in Rs, as of Mar 2025, the value is -1.52. The value appears strong and on an upward trend. It has increased from -2.05 (Dec 2024) to -1.52, marking an increase of 0.53.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: November 15, 2025, 5:37 am

Growth

Last Updated: September 5, 2025, 1:15 am

Balance Sheet

Last Updated: May 13, 2025, 3:44 pm

Below is a detailed analysis of the balance sheet data for Borosil Renewables Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 13.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 13.00 Cr..
• For Reserves, as of Mar 2025, the value is 984.00 Cr.. The value appears strong and on an upward trend. It has increased from 860.00 Cr. (Mar 2024) to 984.00 Cr., marking an increase of 124.00 Cr..
• For Borrowings, as of Mar 2025, the value is 252.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 576.00 Cr. (Mar 2024) to 252.00 Cr., marking a decrease of 324.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 205.00 Cr.. The value appears to be improving (decreasing). It has decreased from 235.00 Cr. (Mar 2024) to 205.00 Cr., marking a decrease of 30.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 1,454.00 Cr.. The value appears to be improving (decreasing). It has decreased from 1,684.00 Cr. (Mar 2024) to 1,454.00 Cr., marking a decrease of 230.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 777.00 Cr.. The value appears to be declining and may need further review. It has decreased from 928.00 Cr. (Mar 2024) to 777.00 Cr., marking a decrease of 151.00 Cr..
• For CWIP, as of Mar 2025, the value is 135.00 Cr.. The value appears strong and on an upward trend. It has increased from 126.00 Cr. (Mar 2024) to 135.00 Cr., marking an increase of 9.00 Cr..
• For Investments, as of Mar 2025, the value is 50.00 Cr.. The value appears strong and on an upward trend. It has increased from 12.00 Cr. (Mar 2024) to 50.00 Cr., marking an increase of 38.00 Cr..
• For Other Assets, as of Mar 2025, the value is 493.00 Cr.. The value appears to be declining and may need further review. It has decreased from 618.00 Cr. (Mar 2024) to 493.00 Cr., marking a decrease of 125.00 Cr..
• For Total Assets, as of Mar 2025, the value is 1,454.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,684.00 Cr. (Mar 2024) to 1,454.00 Cr., marking a decrease of 230.00 Cr..

Notably, the Reserves (984.00 Cr.) exceed the Borrowings (252.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Borosil Renewables Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
• For Basic EPS (Rs.), as of Mar 25, the value is -5.32. This value is below the healthy minimum of 5. It has decreased from -3.59 (Mar 24) to -5.32, marking a decrease of 1.73.
• For Diluted EPS (Rs.), as of Mar 25, the value is -5.32. This value is below the healthy minimum of 5. It has decreased from -3.59 (Mar 24) to -5.32, marking a decrease of 1.73.
• For Cash EPS (Rs.), as of Mar 25, the value is 3.68. This value is within the healthy range. It has decreased from 6.17 (Mar 24) to 3.68, marking a decrease of 2.49.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 75.30. It has increased from 66.88 (Mar 24) to 75.30, marking an increase of 8.42.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 75.30. It has increased from 66.88 (Mar 24) to 75.30, marking an increase of 8.42.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 111.68. It has increased from 104.90 (Mar 24) to 111.68, marking an increase of 6.78.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 7.01. This value is within the healthy range. It has increased from 5.73 (Mar 24) to 7.01, marking an increase of 1.28.
• For PBIT / Share (Rs.), as of Mar 25, the value is -3.21. This value is below the healthy minimum of 0. It has increased from -4.36 (Mar 24) to -3.21, marking an increase of 1.15.
• For PBT / Share (Rs.), as of Mar 25, the value is -5.60. This value is below the healthy minimum of 0. It has decreased from -4.11 (Mar 24) to -5.60, marking a decrease of 1.49.
• For Net Profit / Share (Rs.), as of Mar 25, the value is -6.55. This value is below the healthy minimum of 2. It has decreased from -3.92 (Mar 24) to -6.55, marking a decrease of 2.63.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is -5.25. This value is below the healthy minimum of 2. It has decreased from -3.59 (Mar 24) to -5.25, marking a decrease of 1.66.
• For PBDIT Margin (%), as of Mar 25, the value is 6.27. This value is below the healthy minimum of 10. It has increased from 5.46 (Mar 24) to 6.27, marking an increase of 0.81.
• For PBIT Margin (%), as of Mar 25, the value is -2.87. This value is below the healthy minimum of 10. It has increased from -4.15 (Mar 24) to -2.87, marking an increase of 1.28.
• For PBT Margin (%), as of Mar 25, the value is -5.01. This value is below the healthy minimum of 10. It has decreased from -3.91 (Mar 24) to -5.01, marking a decrease of 1.10.
• For Net Profit Margin (%), as of Mar 25, the value is -5.86. This value is below the healthy minimum of 5. It has decreased from -3.73 (Mar 24) to -5.86, marking a decrease of 2.13.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is -4.70. This value is below the healthy minimum of 8. It has decreased from -3.42 (Mar 24) to -4.70, marking a decrease of 1.28.
• For Return on Networth / Equity (%), as of Mar 25, the value is -6.97. This value is below the healthy minimum of 15. It has decreased from -5.37 (Mar 24) to -6.97, marking a decrease of 1.60.
• For Return on Capital Employeed (%), as of Mar 25, the value is -3.57. This value is below the healthy minimum of 10. It has increased from -4.18 (Mar 24) to -3.57, marking an increase of 0.61.
• For Return On Assets (%), as of Mar 25, the value is -4.78. This value is below the healthy minimum of 5. It has decreased from -2.78 (Mar 24) to -4.78, marking a decrease of 2.00.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.16. This value is below the healthy minimum of 0.2. It has decreased from 0.48 (Mar 24) to 0.16, marking a decrease of 0.32.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.25. This value is within the healthy range. It has decreased from 0.65 (Mar 24) to 0.25, marking a decrease of 0.40.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.94. It has increased from 0.82 (Mar 24) to 0.94, marking an increase of 0.12.
• For Current Ratio (X), as of Mar 25, the value is 1.86. This value is within the healthy range. It has increased from 1.85 (Mar 24) to 1.86, marking an increase of 0.01.
• For Quick Ratio (X), as of Mar 25, the value is 0.95. This value is below the healthy minimum of 1. It has decreased from 1.09 (Mar 24) to 0.95, marking a decrease of 0.14.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 6.12. This value is within the healthy range. It has increased from 5.37 (Mar 24) to 6.12, marking an increase of 0.75.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 2.94. This value is below the healthy minimum of 3. It has increased from 2.56 (Mar 24) to 2.94, marking an increase of 0.38.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is -1.75. This value is below the healthy minimum of 3. It has increased from -1.86 (Mar 24) to -1.75, marking an increase of 0.11.
• For Enterprise Value (Cr.), as of Mar 25, the value is 6,524.34. It has decreased from 6,927.23 (Mar 24) to 6,524.34, marking a decrease of 402.89.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 4.41. This value exceeds the healthy maximum of 3. It has decreased from 5.06 (Mar 24) to 4.41, marking a decrease of 0.65.
• For EV / EBITDA (X), as of Mar 25, the value is 70.28. This value exceeds the healthy maximum of 15. It has decreased from 92.55 (Mar 24) to 70.28, marking a decrease of 22.27.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 4.29. This value exceeds the healthy maximum of 3. It has decreased from 4.75 (Mar 24) to 4.29, marking a decrease of 0.46.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Price / BV (X), as of Mar 25, the value is 6.36. This value exceeds the healthy maximum of 3. It has decreased from 7.45 (Mar 24) to 6.36, marking a decrease of 1.09.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 4.29. This value exceeds the healthy maximum of 3. It has decreased from 4.75 (Mar 24) to 4.29, marking a decrease of 0.46.
• For EarningsYield, as of Mar 25, the value is -0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded -0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness